This report from Life Science Intelligence provides the latest market data for the Global Transcatheter Pulmonary Heart Valves Market. Information covered by this report includes:
The global market for transcatheter pulmonary heart valves is expected to reach $61.8 million in 2020 and is expected to grow at a CAGR (2020-2024) of 19.9%. Market segments covered within this report include transcatheter pulmonary valve implants for valve repair and replacement.
This report covers the impact of COVID-19 on the transcatheter pulmonary heart valves market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Medtronic, Edwards Lifesciences, and CryoLife. The report provides insights into trends, drivers, and limiters of the transcatheter pulmonary heart valves market, as well as highlights potential opportunities.
Growth in the transcatheter pulmonary heart valves market was flat due to the impact of COVID-19 in most countries. The decline in procedures was very strident and is expected to rebound by Q4 2020 and reach pre-COVID-19 levels by early 2021.